FDA Issues Caution on Unapproved Blood Sugar Monitoring Wearables: Navigating the Risks of Noninvasive Glucose Tracking

By |February 22, 2024|Blogging|

FDA Issues Caution on Unapproved Blood Sugar Monitoring Wearables: Navigating the Risks of Noninvasive Glucose Tracking. The U.S. Food and Drug Administration (FDA) has recently issued a warning regarding the use of smartwatches and rings that advertise the ability to measure blood glucose levels without the need for needle pricks. This advisory encompasses devices [...]

Comments Off on FDA Issues Caution on Unapproved Blood Sugar Monitoring Wearables: Navigating the Risks of Noninvasive Glucose Tracking
Go to Top